Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

NCT00967616 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00967616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00967616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
Lead sponsor
Daiichi Sankyo
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
April 30, 2013
Enrollment
100 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, neoplasms, colorectal